I think it will have enough cash (after tomorrow) for: the percutaneous trial (20 patients), to finish the current folfirinox study, to complete FDA application process for cholangio and to retry the TGA.
The GBA application isn't requiring cash and is meant to be cash flow positive if they get it (as opposed to the above which require company funding).
Of course they want commercial agreements and they have implemented quite a few. The more sales the less pressure on the company to raise capital. But they haven't given guidance on expected sales as yet. I'm not saying they don;t need sales, they obviously do. But the other things they are doing are very valuable
- Forums
- ASX - By Stock
- Ann: Two more PANCOSIL Trial treatments using OncoSil device
I think it will have enough cash (after tomorrow) for: the...
-
- There are more pages in this discussion • 161 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.4¢ |
Change
-0.001(11.1%) |
Mkt cap ! $13.32M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $23.68K | 4.971M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 23118264 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 5200224 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 20618264 | 0.004 |
8 | 4673547 | 0.003 |
6 | 5457516 | 0.002 |
4 | 7800000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 5200224 | 7 |
0.006 | 20507648 | 25 |
0.007 | 24737500 | 19 |
0.008 | 9543848 | 10 |
0.009 | 12462253 | 5 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online